GlassScriptPhysician profile
Harvey Gutman
NPI 1427004175
$3,599.34
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $995 · 2020: $263 · 2021: $976 · 2022: $1,186 · 2023: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $178.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $848.51 | 2019-2023 | Erleada |
| Astellas Pharma US INC | $455.07 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $364.69 | 2019-2023 | Xarelto |
| Abbvie INC. | $222.73 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $191.66 | 2019-2023 | Edex, Xiaflex, Aveed |
| Pfizer INC. | $190.29 | 2019-2022 | |
| Shionogi INC | $173.01 | 2021-2023 | Fetroja |
| Dendreon Pharmaceuticals LLC | $170.99 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $160.92 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $148.80 | 2019-2023 | |
| Procept Biorobotics Corporation | $148.35 | 2021 | |
| Teleflex LLC | $135.54 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $62.95 | 2019 | |
| Acerus Pharmaceuticals Corporation | $54.64 | 2022 | |
| Neotract INC. | $47.73 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $43.46 | 2021-2022 | |
| Blue Earth Diagnostics | $28.45 | 2022 | |
| Melinta Therapeutics, LLC | $28.21 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $20.34 | 2022 | |
| Myovant Sciences INC. | $18.75 | 2021 | |
| Boston Scientific Corporation | $17.75 | 2019 | |
| Photocure INC | $17.56 | 2022 | |
| La Jolla Pharmaceutical Company | $16.68 | 2023 | Xerava |
| Smith+Nephew, INC. | $16.30 | 2022 | |
| Accord Healthcare, INC. | $15.96 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harvey Gutman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.